Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 403 M454.9 M— — Research & development ——— — Operating income 39.5 M34.7 M-588.1 M — Non-Operating Income, Total 64.4 M18.4 M4.2 M — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 61.3 M17.7 M4.2 M — Unusual income/expense 3.1 M700 K— — Pretax income 11.6 M162.7 M210.4 M — Equity in earnings 1.1 M600 K— — Taxes 23.8 M34.2 M39.9 M — Non-controlling/minority interest 1.9 M1.7 M— — After tax other income/expense ——— — Net income before discontinued operations 14.1 M198.6 M29.7 M — Discontinued operations 00— — Net income 14.1 M198.6 M29.7 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 14.1 M198.6 M29.7 M — Basic earnings per share (Basic EPS) -0.14-0.7— — Diluted earnings per share (Diluted EPS) -0.14-0.70.11 — Average basic shares outstanding 100281.96 M266.92 M — Diluted shares outstanding 100281.96 M266.92 M — EBITDA 267 M210.7 M— — EBIT 113.2 M43.8 M— — Cost of revenue 449.2 M466.9 M— — Other cost of goods sold 449.2 M466.9 M— — Depreciation & amortization (cash flow) 153.8 M166.9 M544.1 M —